Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma

Wang, M. L., Jurczak, W., Zinzani, P. L., Eyre, T. A., Cheah, C. Y., Ujjani, C. S., Koh, Y., Izutsu, K., Gerson, J. N., Flinn, I., Tessoulin, B., Alencar, A. J., Ma, S., Lewis, D., Lech-Maranda, E., Rhodes, J., Patel, K., Maddocks, K., Lamanna, N., … Shah, N. N. (2023). Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma. Journal of Clinical Oncology, 41(24), 3988–3997. https://doi.org/10.1200/jco.23.00562
Authors:
Michael Wang
Wojciech Jurczak
Pier Luigi Zinzani
Toby A. Eyre
Chan Y. Cheah
Chaitra S. Ujjani
Youngil Koh
Koji Izutsu
James N. Gerson
Ian W. Flinn
Benoît Tessoulin
Alvaro J. Alencar
Shuo Ma
David John Lewis
Ewa Lech‐Marańda
Joanna Rhodes
Krish Patel
Kami J. Maddocks
Nicole Lamanna
Yucai Wang
Constantine S. Tam
Talha Munir
Hirokazu Nagai
Francisco J. Hernandez‐Ilizaliturri
Anita Kumar
Timothy S. Fenske
John F. Seymour
Andrew D. Zelenetz
Binoj C. Nair
Donald E. Tsai
Minna Balbas
Richard A. Walgren
Paolo Abada
Chunxiao Wang
Junjie Zhao
Anthony R. Mato
Nirav N. Shah
Affiliated Authors:
Nicole Lamanna
Publication Type:
Article
Unique ID:
10.1200/jco.23.00562
PMID:
Publication Date:
Data Source:
OpenAlex

Record Created: